Resultats de la cerca - Pfisterer, Jacobus
- Mostrar 1 - 17 resultats de 17
-
1
-
2
-
3
-
4
Tubo-Ovarian Transitional Cell Carcinoma and High Grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles per Magrill, Jamie, Karnezis, Anthony N., Tessier-Cloutier, Basile, Talhouk, Aline, Kommoss, Stefan, Cochrane, Dawn, Chow, Christine, Cheng, Angela, Soslow, Robert, Hauptmann, Steffen, du Bois, Andreas, Pfisterer, Jacobus, Gilks, C Blake, Huntsman, David G., Kommoss, Friedrich
Publicat 2019Text -
5
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian can... per González Martín, Antonio, Oza, Amit M., Embleton, Andrew C., Pfisterer, Jacobus, Ledermann, Jonathan A., Pujade-Lauraine, Eric, Kristensen, Gunnar, Bertrand, Monique A., Beale, Philip, Cervantes, Andrés, Kent, Emma, Kaplan, Richard S., Parmar, Mahesh K.B., Scotto, Nana, Perren, Timothy J.
Publicat 2019Text -
6
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 ran... per Stark, Dan, Nankivell, Matthew, Pujade-Lauraine, Eric, Kristensen, Gunnar, Elit, Lorraine, Stockler, Martin, Hilpert, Felix, Cervantes, Andrés, Brown, Julia, Lanceley, Anne, Velikova, Galina, Sabate, Eduardo, Pfisterer, Jacobus, Carey, Mark S, Beale, Philip, Qian, Wendi, Swart, Ann Marie, Oza, Amit, Perren, Tim
Publicat 2013Text -
7
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions per Winterhoff, Boris, Kommoss, Stefan, Heitz, Florian, Konecny, Gottfried E, Dowdy, Sean C, Mullany, Sally A, Park-Simon, Tjoung-Won, Baumann, Klaus, Hilpert, Felix, Brucker, Sara, du Bois, Andreas, Schröder, Willibald, Burges, Alexander, Shen, Steven, Wang, Jinhua, Tourani, Roshan, Ma, Sisi, Pfisterer, Jacobus, Aliferis, Constantin F.
Publicat 2018Text -
8
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era per You, Benoit, Van Wagensveld, Lilian, Tod, Michel, Sonke, Gabe S., Horlings, Hugo M., Kruitwagen, R. F. P. M., Du Bois, Andreas, Selle, Frédéric, Perren, Timothy, Pfisterer, Jacobus, Joly, Florence, Cook, Adrian, Kaminsky, Marie Christine, Wollschlaeger, Kerstin, Lortholary, Alain, Tome, Oliver, Leary, Alexandra, Freyer, Gilles, Van Der Aa, Maaike, Colomban, Olivier
Publicat 2022Text -
9
Proteomic analysis of transitional cell carcinoma—like variant of tubo-ovarian high-grade serous carcinoma*(,)** per Tessier-Cloutier, Basile, Cochrane, Dawn R., Karnezis, Anthony N., Colborne, Shane, Magrill, Jamie, Talhouk, Aline, Zhang, Jonathan, Leung, Samuel, Hughes, Christopher S., Piskorz, Anna, Cheng, Angela S., Greening, Kendall, du Bois, Andreas, Pfisterer, Jacobus, Soslow, Robert A., Kommoss, Stefan, Brenton, James D., Morin, Gregg B., Gilks, C. Blake, Huntsman, David G., Kommoss, Friedrich
Publicat 2020Text -
10
Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovar... per Heitz, Florian, Kommoss, Stefan, Tourani, Roshan, Grandelis, Anthony, Uppendahl, Locke, Aliferis, Constantin, Burges, Alexander, Wang, Chen, Canzler, Ulrich, Wang, Jinhua, Belau, Antje, Prader, Sonia, Hanker, Lars, Ma, Sisi, Ataseven, Beyhan, Hilpert, Felix, Schneider, Stephanie, Sehouli, Jalid, Kimmig, Rainer, Kurzeder, Christian, Schmalfeldt, Barbara, Braicu, Elena I., Harter, Philipp, Dowdy, Sean C., Winterhoff, Boris J., Pfisterer, Jacobus, du Bois, Andreas
Publicat 2019Text -
11
Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes per Kommoss, Stefan, Winterhoff, Boris, Oberg, Ann L., Konecny, Gottfried E., Wang, Chen, Riska, Shaun M., Fan, Jian-Bing, Maurer, Matthew J., April, Craig, Shridhar, Viji, Kommoss, Friedrich, du Bois, Andreas, Hilpert, Felix, Mahner, Sven, Baumann, Klaus, Schroeder, Willibald, Burges, Alexander, Canzler, Ulrich, Chien, Jeremy, Embleton, Andrew C., Parmar, Mahesh, Kaplan, Richard, Perren, Timothy, Hartmann, Lynn C., Goode, Ellen L., Dowdy, Sean C., Pfisterer, Jacobus
Publicat 2017Text -
12
Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study per Sabbatini, Paul, Harter, Philipp, Scambia, Giovanni, Sehouli, Jalid, Meier, Werner, Wimberger, Pauline, Baumann, Klaus H., Kurzeder, Christian, Schmalfeldt, Barbara, Cibula, David, Bidzinski, Mariusz, Casado, Antonio, Martoni, Andrea, Colombo, Nicoletta, Holloway, Robert W., Selvaggi, Luigi, Li, Andrew, del Campo, Jose, Cwiertka, Karel, Pinter, Tamas, Vermorken, Jan B., Pujade-Lauraine, Eric, Scartoni, Simona, Bertolotti, Monica, Simonelli, Cecilia, Capriati, Angela, Maggi, Carlo Alberto, Berek, Jonathan S., Pfisterer, Jacobus
Publicat 2013Text -
13
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial per Fumet, Jean-David, Lardenois, Emilie, Ray-Coquard, Isabelle, Harter, Philipp, Joly, Florence, Canzler, Ulrich, Truntzer, Caroline, Tredan, Olivier, Liebrich, Clemens, Lortholary, Alain, Pissaloux, Daniel, Leary, Alexandra, Pfisterer, Jacobus, Eeckhoutte, Alexandre, Hilpert, Felix, Fabbro, Michel, Caux, Christophe, Alexandre, Jérôme, Houlier, Aurélie, Sehouli, Jalid, Sohier, Emilie, Kimmig, Rainer, Dubois, Bertrand, Spaeth, Dominique, Treilleux, Isabelle, Frenel, Jean-Sébastien, Herwig, Uwe, Le Saux, Olivia, Bendriss-Vermare, Nathalie, du Bois, Andreas
Publicat 2022Text -
14
Pelvic Lymphadenectomy in Vulvar Cancer – Does it make sense? per Woelber, Linn, Bommert, Mareike, Prieske, Katharina, Fischer, Inger, zu Eulenburg, Christine, Vettorazzi, Eik, Harter, Philipp, Jueckstock, Julia, Hilpert, Felix, de Gregorio, Niko, Iborra, Severine, Sehouli, Jalid, Ignatov, Atanas, Hillemanns, Peter, Fuerst, Sophie, Strauss, Hans-Georg, Baumann, Klaus, Beckmann, Matthias, Mustea, Alexander, Meier, Werner, Wimberger, Pauline, Hanker, Lars, Canzler, Ulrich, Fehm, Tanja, Luyten, Alexander, Hellriegel, Martin, Kosse, Jens, Heiss, Christoph, Hantschmann, Peer, Mallmann, Peter, Tanner, Berno, Pfisterer, Jacobus, Mahner, Sven, Schmalfeldt, Barbara, Jaeger, Anna
Publicat 2020Text -
15
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) per Harter, Philipp, Hauke, Jan, Heitz, Florian, Reuss, Alexander, Kommoss, Stefan, Marmé, Frederik, Heimbach, André, Prieske, Katharina, Richters, Lisa, Burges, Alexander, Neidhardt, Guido, de Gregorio, Nikolaus, El-Balat, Ahmed, Hilpert, Felix, Meier, Werner, Kimmig, Rainer, Kast, Karin, Sehouli, Jalid, Baumann, Klaus, Jackisch, Christian, Park-Simon, Tjoung-Won, Hanker, Lars, Kröber, Sandra, Pfisterer, Jacobus, Gevensleben, Heidrun, Schnelzer, Andreas, Dietrich, Dimo, Neunhöffer, Tanja, Krockenberger, Mathias, Brucker, Sara Y., Nürnberg, Peter, Thiele, Holger, Altmüller, Janine, Lamla, Josefin, Elser, Gabriele, du Bois, Andreas, Hahnen, Eric, Schmutzler, Rita
Publicat 2017Text -
16
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci per Glubb, Dylan M., Johnatty, Sharon E., Quinn, Michael C.J., O’Mara, Tracy A., Tyrer, Jonathan P., Gao, Bo, Fasching, Peter A., Beckmann, Matthias W., Lambrechts, Diether, Vergote, Ignace, Velez Edwards, Digna R., Beeghly-Fadiel, Alicia, Benitez, Javier, Garcia, Maria J., Goodman, Marc T., Thompson, Pamela J., Dörk, Thilo, Dürst, Matthias, Modungo, Francesmary, Moysich, Kirsten, Heitz, Florian, du Bois, Andreas, Pfisterer, Jacobus, Hillemanns, Peter, Karlan, Beth Y., Lester, Jenny, Goode, Ellen L., Cunningham, Julie M., Winham, Stacey J., Larson, Melissa C., McCauley, Bryan M., Kjær, Susanne Krüger, Jensen, Allan, Schildkraut, Joellen M., Berchuck, Andrew, Cramer, Daniel W., Terry, Kathryn L., Salvesen, Helga B., Bjorge, Line, Webb, Penny M., Grant, Peter, Pejovic, Tanja, Moffitt, Melissa, Hogdall, Claus K., Hogdall, Estrid, Paul, James, Glasspool, Rosalind, Bernardini, Marcus, Tone, Alicia, Huntsman, David, Woo, Michelle, Group, AOCS, deFazio, Anna, Kennedy, Catherine J., Pharoah, Paul D.P., MacGregor, Stuart, Chenevix-Trench, Georgia
Publicat 2017Text -
17
Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer per Quinn, Michael C. J., McCue, Karen, Shi, Wei, Johnatty, Sharon E., Beesley, Jonathan, Civitarese, Andrew, O’Mara, Tracy A., Glubb, Dylan M., Tyrer, Jonathan P., Armasu, Sebastian M., Ong, Jue Sheng, Gharahkhani, Puya, Lu, Yi, Gao, Bo, Patch, Ann-Marie, Fasching, Peter A., Beckmann, Matthias W., Lambrechts, Diether, Vergote, Ignace, Velez Edwards, Digna R., Beeghly-Fadiel, Alicia, Benitez, Javier, Garcia, Maria J., Goodman, Marc T., Dörk, Thilo, Dürst, Matthias, Modugno, Francesmary, Moysich, Kirsten, du Bois, Andreas, Pfisterer, Jacobus, Baumann, Klaus, Karlan, Beth Y, Lester, Jenny, Cunningham, Julie M., Larson, Melissa C., McCauley, Bryan M., Kjær, Susanne K., Jensen, Allan, Hogdall, Claus K., Hogdall, Estrid, Schildkraut, Joellen M., Riggan, Marjorie J., Berchuck, Andrew, Cramer, Daniel W., Terry, Kathryn L., Bjorge, Line, Webb, Penelope M., Friedlander, Michael, Pejovic, Tanja, Moffitt, Melissa, Glasspool, Rosalind, May, Taymaa, Ene, Gabrielle E.V., Huntsman, David G., Woo, Michelle, Carney, Michael E., Hinsley, Samantha, Heitz, Florian, Fereday, Sian, Kennedy, Catherine J, Edwards, Stacey L., Winham, Stacey J., deFazio, Anna, Pharoah, Paul D.P., Goode, Ellen L., MacGregor, Stuart, Chenevix-Trench, Georgia
Publicat 2021Text